Home・Lista de Ações・Zealand Pharma A-S

Zealand Pharma A-S

Fechado

292.7 -2.07

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

290.1

Máximo

293.5

Indicadores-chave
By Trading Economics
Rendimento	-15M -394M
Vendas	-35M 34M
P/E Médio do Setor	3.155 60.149
EPS	-5.58
Margem de lucro	-1,158.824
Funcionários	544
EBITDA	124M -379M

Recomendações
By TipRanks
Recomendações	Neutro
Previsão para 12 meses	+25.15% upside

Dividendos
By Acuity
Próximos Ganhos	13 de ago. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-1.6B 19B
Abertura anterior	294.77
Fecho anterior	292.7

Zealand Pharma A-S Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

18 de jul. de 2026, 23:51 UTC

Cryptocurrency Gains Amid Investor Shift from Gold, While Geopolitical Tensions and Economic Data Loom Over Financial Markets.

18 de jul. de 2026, 23:51 UTC

Bitcoin and Ethereum rise amid investor shift from gold, while geopolitical tensions and U.S. Treasury shifts signal potential market volatility ahead of key economic data releases.

18 de jul. de 2026, 23:51 UTC

Bitcoin and Ethereum rise as investors shift from gold amid market volatility, while U.S. labor participation hits a 50-year low and geopolitical tensions escalate in the Middle East.

18 de jul. de 2026, 23:51 UTC

Bitcoin and Ethereum gain momentum amid investor shift from gold, while geopolitical tensions and upcoming economic data influence market sentiment.

18 de jul. de 2026, 23:41 UTC

Canada's Retail Sales Ex Autos MoM report on July 23, 2026, forecasts modest growth at 0.4%, amid cautious market sentiment due to geopolitical tensions and economic uncertainties.

18 de jul. de 2026, 23:41 UTC

Chicago Fed National Activity Index Release on July 23, 2026, Expected to Reflect Economic Fluctuations Amid Geopolitical Tensions and Rising Oil Prices.

18 de jul. de 2026, 23:31 UTC

ECB Set to Raise Interest Rates Amid Rising Inflation Concerns Driven by Geopolitical Tensions on July 23, 2026.

18 de jul. de 2026, 23:31 UTC

Euro Area's Deposit Facility Rate Expected to Hold Steady at 2.25% Amid Geopolitical Tensions and Inflation Concerns

18 de jul. de 2026, 23:21 UTC

China's Loan Prime Rate (LPR) 1Y set for July 20, 2026 at a forecasted 0.03%, amid cautious investor sentiment and rising inflation concerns.

18 de jul. de 2026, 23:21 UTC

China's Loan Prime Rate Expected to Remain Steady at 3.50% for Five Years Amid Stable Market Sentiment

18 de jul. de 2026, 22:51 UTC

Japan's Inflation Rate YoY Release on July 23, 2026 Sparks Concerns Over Economic Pressures and Market Volatility Amid Rising Interest Rates.

18 de jul. de 2026, 22:51 UTC

Japan's Core Inflation Rate YoY Expected to Rise to 1.6% Amidst CFO Concerns Over Economic Pressures and Geopolitical Tensions

18 de jul. de 2026, 22:41 UTC

Mortgage Rates Hit Nine-Month High Amid Inflation Concerns and Cautious Market Sentiment Ahead of Upcoming Data Release.

18 de jul. de 2026, 22:41 UTC

Canada's Inflation Rate Expected to Drop Significantly Amid Geopolitical Tensions and Recent Price Declines

18 de jul. de 2026, 22:41 UTC

Canada's Inflation Rate Expected to Decline Slightly in June Amid Geopolitical Tensions and Volatile Market Conditions

18 de jul. de 2026, 22:41 UTC

Canada's Core Inflation Rate Release on July 20, 2026: Market Anticipates Lower Figures Amid Geopolitical Tensions and Recent CPI Drop.

18 de jul. de 2026, 22:31 UTC

Japan's June 2026 export growth forecasted at 0.186%, amid market volatility and geopolitical tensions impacting major exporters.

18 de jul. de 2026, 22:31 UTC

Japan's Balance of Trade report predicts a -120 billion yen deficit amid rising import costs and negative market sentiment, as stock indices decline due to global economic concerns.

18 de jul. de 2026, 22:31 UTC

Brazil's Central Bank to announce SELIC interest rate decision on July 20, 2026, amid stable market sentiment.

18 de jul. de 2026, 22:31 UTC

UK Consumer Confidence Expected to Decline to -21.0 Amid Rising Inflation and Geopolitical Tensions

18 de jul. de 2026, 22:21 UTC

Australia's S&P Global Services PMI Flash Release on July 23, 2026: Key Indicator Amid Mixed Market Sentiment and Inflation Concerns.

18 de jul. de 2026, 22:21 UTC

Optimism Grows Ahead of Australia's S&P Global Manufacturing PMI Flash Release Amid Strong Industrial Performance and Positive Investor Sentiment

18 de jul. de 2026, 22:11 UTC

Turkey's TCMB Expected to Maintain 37% Interest Rate Amid Inflation Pressures and Geopolitical Tensions on July 23, 2026.

18 de jul. de 2026, 22:01 UTC

South Korea's Q2 GDP Growth Rate Estimate Set for July 22 Amid Cautious Optimism and External Concerns.

18 de jul. de 2026, 22:01 UTC

South Korea's Upcoming GDP Growth Rate Release on July 22, 2026, Sparks Investor Anxiety Amid Geopolitical Tensions and Foreign Sell-Offs.

18 de jul. de 2026, 21:11 UTC

UK Factory Orders Forecasted at -40.0 Amid Mixed Sentiment and Economic Pressures Ahead of July 2026 Release

18 de jul. de 2026, 21:11 UTC

UK CBI Business Optimism Index for Q3 2026 set to reveal cautious optimism amid geopolitical tensions and inflationary pressures.

18 de jul. de 2026, 20:51 UTC

Correlated Moves

Macro News

Bitcoin is trading higher today amid rising geopolitical tensions and crude oil prices. Ethereum's movement reflects similar market dynamics in the cryptocurrency sector.

18 de jul. de 2026, 20:01 UTC

Macro News

Crude oil prices rose in after-market hours amid escalating geopolitical tensions affecting shipping routes, particularly following military actions involving Iran and U.S. forces.

18 de jul. de 2026, 20:01 UTC

API Crude Oil Stock Change Report Set for July 21, Amid Geopolitical Tensions Driving Price Volatility and Supply Concerns.

Comparação entre Pares

Variação de preço

Zealand Pharma A-S Previsão

Preço-alvo

By TipRanks

25.15% parte superior

Previsão para 12 meses

Média 270.582 DKK 25.15%

Máximo 270.568 DKK

Mínimo 270.568 DKK

Com base em 1 analistas de Wall Street que oferecem metas de preço de 12 meses para Zealand Pharma A-S - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

1 ratings

Comprar

Manter

Vender

Com base em 1 analistas que deram avaliações de ações para Zealand Pharma A-S - Dist nos últimos 3 meses.

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Zealand Pharma A-S

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.